These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9010617)

  • 1. Functional design of potential inhibitors of human immunodeficiency virus (HIV) binding to CD4+ target cells: a molecular model of gp120 predicts ligand binding.
    Gabriel JL; Mitchell WM
    Drug Des Discov; 1996 Oct; 14(2):103-14. PubMed ID: 9010617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
    Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
    Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
    Caporuscio F; Tafi A; González E; Manetti F; Esté JA; Botta M
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6087-91. PubMed ID: 19783140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic mimetics of the CD4 binding site of HIV-1 gp120 for the design of immunogens.
    Franke R; Hirsch T; Overwin H; Eichler J
    Angew Chem Int Ed Engl; 2007; 46(8):1253-5. PubMed ID: 17211914
    [No Abstract]   [Full Text] [Related]  

  • 6. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.
    Hsu ST; Bonvin AM
    Proteins; 2004 May; 55(3):582-93. PubMed ID: 15103622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of putative, stable binding regions through flexibility analysis of HIV-1 gp120.
    Tan H; Rader AJ
    Proteins; 2009 Mar; 74(4):881-94. PubMed ID: 18704932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
    Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
    Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV requires multiple gp120 molecules for CD4-mediated infection.
    Layne SP; Merges MJ; Dembo M; Spouge JL; Nara PL
    Nature; 1990 Jul; 346(6281):277-9. PubMed ID: 2374593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
    Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
    Yang J; Liu CQ
    Acta Pharmacol Sin; 2000 Jan; 21(1):29-34. PubMed ID: 11263244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
    Zhang X; Gaubin M; Briant L; Srikantan V; Murali R; Saragovi U; Weiner D; Devaux C; Autiero M; Piatier-Tonneau D; Greene MI
    Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the V3 loop involved in HIV binding to CD4?
    Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
    Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth.
    Huang CC; Stricher F; Martin L; Decker JM; Majeed S; Barthe P; Hendrickson WA; Robinson J; Roumestand C; Sodroski J; Wyatt R; Shaw GM; Vita C; Kwong PD
    Structure; 2005 May; 13(5):755-68. PubMed ID: 15893666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
    Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
    Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
    Mbemba E; Benjouad A; Saffar L; Gattegno L
    Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.